3

PRIMARY DOCUMENT

Company: Viridian Therapeutics, Inc.\DE
Filed: August 4, 2014
Period of Report: August 4, 2014
Accession Number: 0001288232-14-000003

View Document ↗ View on SEC.gov ↗